Effectiveness of Autonomy Enhancing Therapy in hearing-impaired adults with psychosocial problems and/or mental disorders

• Conditions: 10019243; psycho-social disorder (autonomy deficit); Selfdetermination; selfgouvernance

• Registration Number: NL-OMON51554
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 64

Inclusion Criteria

Hearing loss in the best ear >= 35 dB
and a clinically deviant score on at least one subscale ot the AGS-30 (below
average score)

Exclusion Criteria

Receiving treatment for psychiatric problems or tinnitus.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters /endpoints, outcomes in the psychosocial and mental<br /><br>health domain are evaluated at the end of the experimental phase (T2) with<br /><br>standardized questionnaires. A questionnaire of autonomy-connectedness<br /><br>(Autonomy- Connectedness Scale-30, ACS-30) and questionnaires for anxiety<br /><br>disorder (Symptom Checklist 90-R, SCL-90-R) and depression (Beck Depression<br /><br>Inventory, BDI-II-NL). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>In the secondary phase for clinical-therapeutical purposes the AET is provided<br /><br>to the control group. T3 assessment with standardized questionnaires of<br /><br>autonomy-connectedness and mental disorders is performed to verify effect of<br /><br>therapy for the control group. In case of persisting autonomy-connectedness or<br /><br>mental health disorders these assessments are necessary for referral for<br /><br>further psychological care.<br /><br>In the experimental group T3 the Autonomy-Connectedness scale-30 (ACS-30) is<br /><br>used to assess the retention effect of AET in the experimental group.</p><br>